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Abstract 16 
Decellularised mammalian extracellular matrices (ECM) have been widely accepted as an ideal substrate for 17 
repair and remodelling of numerous tissues in clinical and pre-clinical studies. Recent studies have 18 
demonstrated the ability of ECM scaffolds derived from site-specific homologous tissues to direct cell 19 
differentiation. The present study investigated the suitability of hydrogels derived from different source tissues: 20 
bone, spinal cord and dentine, as suitable carriers to deliver human apical papilla derived mesenchymal stem 21 
cells (SCAP) for spinal cord regeneration. Bone, spinal cord and dentine ECM hydrogels exhibited distinct 22 
structural, mechanical and biological characteristics. All three hydrogels supported SCAP viability and 23 
proliferation. However, only spinal cord and bone derived hydrogels promoted the expression of neural lineage 24 
markers. The specific environment of ECM scaffolds significantly affected the differentiation of SCAP to a 25 
neural lineage, with stronger responses observed with spinal cord ECM hydrogels, suggesting that site-specific 26 
tissues are more likely to facilitate optimal stem cell behaviour for constructive spinal cord regeneration. 27 
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1 Introduction 31 
Traumatic spinal cord injuries (SCI) cause devastating neurological deficits and disabilities.  Initial trauma 32 
leads to immediate disruption of neural tissue by axon shearing, blood vessel rupture and cell death. 33 
Subsequently a cascade of secondary events occurs composed of ischemic injury, inflammation, cell death, 34 
demyelination of axonal tracts and the creation of a glial scar, forming a physical and chemical barrier 1. 35 
Treatment options for SCI have been limited in part due to this complex pathophysiology 2. Cell transplantation 36 
to replace damaged cells, provide trophic support and promote functional recovery is a favourable strategy for 37 
SCI 3.  38 
Stem cells derived from dental tissues are an attractive source for cell transplantation in the central nervous 39 
system (CNS) due to accessible supply, high proliferation rate and the potential for autologous transplantation 40 
4. Human dental stem cells are of neural crest origin, display neural stem cell properties 5, and have recently 41 
been shown to induce functional recovery in SCI repair 6. Whilst several different populations of dental stem 42 
cells have been identified, stem cells of the apical papilla (SCAP) have been shown to possess greater 43 
proliferation potential than dental pulp stem cells 7 and express a variety of neural markers including βIII 44 
tubulin, NeuN, nestin, neurofilament M and glial fibrillary acidic protein (GFAP) 5,8. Recently, whole human 45 
apical papillae implanted into rat hemisected spinal cords induced a significant improvement of rat motor 46 
function 4.  However, SCAP cells transplanted in a fibrin hydrogel in the same study did not have the same 47 
effect upon motor function 4, highlighting the importance of delivering SCAPs in their original niche or a 48 
similarly supportive medium.  The goal of the present work was thus to identify a suitable hydrogel to support 49 
SCAP delivery for SCI.   50 
Biologic scaffolds composed of extracellular matrix (ECM) produced by decellularisation of mammalian 51 
tissues largely retain the functional complexity of their tissues of origin 9. Hydrogel forms of ECM do not 52 
retain the three dimensional ultrastructure of the native tissue but still maintain in vitro and in vivo biologic 53 
activity, including differentiation stimuli for neural stem cells 9,10 and the promotion of an M2 macrophage 54 
phenotype 11,12. In addition, ECM hydrogels may supply signalling molecules and growth factors 13,14 required 55 
to support delivered cells in the CNS 15. Tissue-specific ECM scaffolds, originating from a tissue type 56 
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homologous to the repair site, have previously shown the ability to enhance site appropriate cell phenotypes 57 
compared to ECM scaffolds derived from non-homologous tissues for a range of complex tissues 16-18.  58 
The objectives of the present study were to evaluate the suitability of different ECM derived hydrogels to 59 
support SCAPs for delivery into SCI.  Previously developed protocols were utilised to produce bone and spinal 60 
cord ECM hydrogels (bECMh and scECMh, respectively) and a new method was developed to create a 61 
hydrogel form of human dentine ECM (dECMh). The biomolecular composition, mechanical properties, and 62 
in vitro cytocompatibility of the hydrogels were evaluated. We hypothesised that the different ECM hydrogels 63 
would influence SCAP viability, proliferation and gene expression.  64 
2 Material and methods 65 
2.1 Chemicals and reagents  66 
The Quant-iT™ Picogreen® assay kit and the Presto Blue kit were from Life Technologies (Carlsbad, US).  67 
Bovine serum, L-glutamine, penicillin and streptomycin were from Gemini Bio-Products (Sera Laboratories 68 
International, Bolney, UK). All other reagents were purchased from Sigma-Aldrich (Poole, UK). 69 
2.2  ECM biologic scaffold production 70 
Porcine spinal cord and bovine bone were obtained from market weight animals. Human wisdom teeth were 71 
collected from healthy individuals aged between 16 and 18 years. An informed consent was obtained from all 72 
donors (Approved by the Commission d’Ethique Biomédicale Hospitalo-Facultaire of UCL, 73 
2012/14JUN/283). Female and male donors and animals have been used indiscriminately. Decellularisation of 74 
bone (bECM) 19 and spinal cord (scECM) 20 were performed as described previously. Extraction of ECM from 75 
human dentine (dECM) was performed using the protocol developed for bECM preparation with modifications. 76 
Briefly, teeth were frozen in liquid nitrogen and broken with a Carver press (Carver, #3850, Wabash, US) and 77 
the pulp was removed. The enamel was destroyed by sonication in 10% HCl for 20 min 21. Acid neutralisation 78 
was performed by immersing the tissue in 2 volumes of water containing penicillin-streptomycin (0.5% w/v) 79 
for 1 hr. Demineralisation was performed by incubating tooth fragments in a 0.5M HCl solution under agitation 80 
(300 rpm) for 24 hrs at room temperature. The resultant material was washed thoroughly with deionised water 81 
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and incubated in a 0.05% trypsin-0.025% EDTA solution for 24 hrs at 37°C at 300rpm for enzymatic 82 
decellularisation. Finally, the material was washed with 2 volumes of PBS and freeze dried. 83 
2.3 ECM digestion and solubilisation  84 
Pepsin digestion and solubilisation was used to obtained pre-gel solutions 22,23.  Lyophilised ECM powders 85 
were added to 1mg/ml of pepsin in 0.01 N HCl for a final concentration of 10 mg ECM/ml. The suspension 86 
was stirred at room temperature for 48 hrs for spinal cord ECM, 72 hrs for dentine ECM and 84 hrs for bone 87 
ECM. The resultant pepsin digests were aliquoted and stored at -200C. Gelation of pepsin digests was induced 88 
by neutralisation of salt concentration and pH at 4°C followed by warming to 37°C. Briefly, pepsin digests 89 
were mixed with one tenth volume of 0.01N NaOH, one ninth volume of 10X PBS and made up to desired 90 
volume with 1X PBS. 8 mg/ml of pre-gel solutions were prepared and incubated for 1 hr at 37°C to obtain 91 
spinal cord, bone and dentine hydrogels, denoted scECMh, bECMh and dECMh.  92 
2.4 DNA, collagen and sGAG quantification  93 
Quantitative assessment of DNA in pepsin digests was conducted by an adaptation of previously published 94 
method 23. DNA was extracted from pepsin digests by addition of an equal volume of 25:24:1 (v:v:v) 95 
phenol/chloroform/isoamyl to 1ml of sample (10 mg/ml). Phenol was removed using an equal volume of 24:1 96 
(v:v) chloroform/isoamyl alcohol. DNA was precipitated from the aqueous phase by the addition of 2 volumes 97 
of ice-cold ethanol and 0.1 volume of 3M sodium acetate (pH 5.2) and was frozen at -800C for 30 min. The 98 
frozen DNA was then centrifuged at 13,000 rpm for 10 min and washed with ethanol, dried at room temperature 99 
and resuspended in 0.1 ml of TE buffer. DNA concentration was measured using a Quant-iT™ Picogreen® 100 
assay kit following supplier instructions. A standard curve was prepared with known DNA concentrations from 101 
0 – 100 ng/ml and samples were read using a Tecan Infinite M200 plate reader (Tecan UK, Reading, UK). 102 
Collagen content of pepsin digests was measured by quantifying hydroxyproline 24. Briefly, pepsin digests and 103 
a blank pepsin solution were hydrolysed with 1 volume of concentrated HCl (12N) overnight at 120°C. The 104 
samples were dried by incubation at 90°C for 2 hrs followed by the addition of 4 volumes of 0.25 M sodium 105 
phosphate buffer (pH 6.5). The hydrolysed blank pepsin solution served as a negative control as well as diluent 106 
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for the assay. The samples were oxidised by incubation with 1 volume of 3-Chloramine T solution (0.07M) at 107 
room temperature for 20 min followed by the addition of 4- p-dimethylaminobenzaldehyde (p-DAB) solution 108 
[1.16M p-DAB in 60% perchloric acid (6.5ml) and Isopropanol (15ml)] and incubation at 600C for 30 min. A 109 
standard curve was prepared using known concentrations of hydroxyproline ranging from 0 – 100 µg/ml and 110 
the absorbance was measured at 540nm with a Tecan Infinite M200 plate reader. Collagen content was 111 
determined using the relationship that hydroxyproline forms 14.3% of total amount of collagen 24. 112 
The sulphated glycosaminoglycan (sGAG) content in pepsin digests was determined using the 1, 9–Dimethyl 113 
methylene blue assay (DMMB) 25. One ml of digest was incubated with 0.1mg/ml of Proteinase K (>600U/ml) 114 
overnight at 37°C. A solution of blank pepsin was used as negative control as well as diluent for the assay. 50µl 115 
of sample was mixed with 200 µl of DMMB solution (0.03 M sodium formate, 0.046M DMMB, ethanol (0.5% 116 
v/v) and formic acid (0.2% v/v) in a 96 well plate. A standard curve was constructed using known 117 
concentrations of Chondroitin-4-sulphate from 0 – 75 µg/ml. The absorbance was measured immediately at 118 
525nm. 119 
2.5 ECM-based hydrogel gelation kinetics 120 
Turbidimetric gelation kinetics of ECM-based hydrogels was determined as previously described 26. 121 
Normalised Absorbance (NA) was calculated as shown in Eq. (1).  122 
NA= 
𝐴−𝐴0
𝐴𝑚𝑎𝑥−𝐴𝑜
      (1)  123 
Were A is absorbance at given time, A0 is the initial absorbance and Amax is the maximum absorbance attained 124 
by the sample after inducing gelation. Normalised gelation was used to calculate the time at which 50% of 125 
gelation (t1/2) and 95% of gelation (t 95) occurred. The lag time,  tlag,  was defined as the intercept of the linear 126 
region of the gelation with 0% absorbance 19. Speed of gelation (S) was determined by calculating the slope of 127 
the curve (n=8).  128 
2.6  Rheological characteristics  129 
bECMh, dECMh, and scECMh rheological characteristics were determined as described previously 19  using a 130 
Malvern Kinexus ultra+ rheometer (Malvern Kinexus Pro rotational rheometer and rSpace software, Malvern 131 
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Instruments, Worcestershire, UK). Cold pre-gel solutions were placed between two pre-cooled (4°C) 25 mm 132 
parallel plates separated by a gap of 0.3 mm. For each run, the plates were warmed to reach 37°C (2°C/sec) and 133 
the sample was exposed to 1% oscillatory strain with a constant angular frequency of 2 rad/sec. Data were 134 
recorded every 30 sec (n=3). 135 
2.7 Scanning electron microscopy (SEM) 136 
Gel specimens (300 µl per well) were fixed in 5 % glutaraldehyde at room temperature. Samples were 137 
dehydrated in a graded series of ethanol (25-100%), dried using a critical point dryer (CPD, Balzers Union, 138 
Balzers, FL) and sputter coated with gold using a Cressington 208HR metalizer (ELOISE s.a.r.l., Tremblay, 139 
FR). Images were acquired using a JSM-7600F (JEOL, Zaventem, BE) scanning electron microscope at a 140 
voltage of 15 kV. 141 
2.8 SCAP culture 142 
Previously characterised human stem cells of the apical papilla (SCAP) (RP89 cells) 27 were used between 143 
passages 6 and 9. SCAP were grown at 37°C in 5% CO2 in Minimum Essential Medium (Sigma-Aldrich) 144 
supplemented by 10% bovine serum (Gemini Bio-Products), 1% of L-glutamine (Gemini) and 1% of penicillin 145 
and streptomycin (Gemini) until they reached ~80% confluence. SCAP were then incorporated in the pre-gel 146 
solutions, placed in 96 well plates and incubated at 37°C for 1 hr. 147 
2.9 SCAP viability  148 
Pre- gel solution (10µl) containing 500,000 cells/ml were loaded into µ-Slide Angiogenesis ibiTreat 149 
microscopy chamber (Ibidi, Proxylab, Beloeil, BE) and were allowed to gel (n=3, N=3). After 2 days, a 150 
Live/Dead assay was performed. Pictures (2 fields/sample, Z-stack: 1 picture every 3µm, for a total of 210 151 
pictures/stack) were then acquired with a confocal microscope (LSM700, Zeiss, Zaventem, BE). All the 152 
pictures were merged to count dead and living cells. Cell viability was expressed as a percentage of the number 153 
of living cells compared to the total number of cells.  154 
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2.10 SCAP proliferation 155 
The effect of ECM origin on SCAP proliferation was analysed when cells were encapsulated in the hydrogels 156 
(3D culture) or grown on the surface of hydrogel (2D culture). 157 
2.10.1 SCAP proliferation in 3D culture 158 
Pre-gel solutions containing 500,000 SCAP/ml were placed in 96 well plates (N=3, n=6) and incubated for 1hr 159 
at 37°C to initiate gel formation. Pre-gel solution (100µl) without cells was used as a control. Independent 160 
samples were prepared for each time point. After 2, 7 and 14 days, cell proliferation was analysed using a 161 
Presto Blue kit. The fluorescence intensities (590 nm) were measured 2 hours after the addition of the Presto 162 
Blue reagent. Values obtained for hydrogels without cells were used as background and subtracted from values 163 
obtained for hydrogels with cells. A standard curve (from 13,000 to 250,000 cells) was used to correlate the 164 
fluorescence intensity with cell number. Cell number fold increase was calculated by dividing the number of 165 
cells at day 2, 7 or 14 by the initial number of seeded cells. Samples were collected and frozen at -80°C for 166 
further processing for PCR analysis. 167 
2.10.2 SCAP proliferation in 2D culture 168 
Pre-gel solutions (20µl) were placed in 96 well plates and allowed to gel for 1 hr at 37°C.  Two thousands cells 169 
were seeded onto the surface of the hydrogels (N=3, n=6). Cell proliferation was evaluated as described for 170 
2.10.1.  171 
2.11 SCAP gene expression 172 
Total mRNA was extracted using the phenol/chloroform extraction method. One microgram of mRNA was 173 
reverse transcribed using the Reverse Transcription System kit (Promega, Madison, USA) (n=3). The resulting 174 
cDNA was used as template for 30 cycles of semi-quantitative polymerase chain reaction in a T100 TM thermo 175 
cycler (Bio-Rad, BE). Primer sequences are summarized in Table 1. The PCR products were pooled and 176 
subjected to electrophoresis on Syber™Safe (Invitrogen, BE) stained 2% agarose gel. mRNA relative 177 
expression of tested genes was normalised with GAPDH. 178 
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2.12 Statistical analysis 179 
Statistical analyses were performed using PRISM (GraphPad software, CA, USA) and JMP10 (SAS, NC, 180 
USA). Two-way ANOVA with post hoc Bonferroni’s multiple comparison tests as well as Tukey’s HSD were 181 
performed with a P-value of 0.05. Errors bars represent the standard deviation (SD) in all figures. 182 
3 Results 183 
3.1 Influence of ECM origin on cellular, collagen and sGAG content 184 
Determination of decellularisation efficiency was based upon quantification of dsDNA. Regardless of origin, 185 
all three ECMs contained less than 50 ng/mg of dsDNA (Figure 1A). Concentrations of nucleic acid of bECM, 186 
dECM and scECM were significantly different with the lowest quantity detected in scECM; bECM, dECM 187 
and scECM contained 17.8±1.5 ng of DNA/mg, 13.56±0.5 ng of DNA/mg and 6.8±0.17 ng of DNA/mg, 188 
respectively. No significant difference was observed between the collagen content of the three ECMs, although 189 
scECM tended to contain less collagen (Figure 1B); bECM, dECM and scECM contained 84.28±10.20 %, 190 
83.16±5.55 % and 67.41±23.16 % of collagen, respectively. Significantly more sGAG was detected in scECM 191 
(0.65 % of dry weight) compared to bECM and dECM (0.3 % and 0%, respectively) (Figure 1C).  192 
3.2 Influence of ECM origin on hydrogel gelation kinetics 193 
The gelation kinetics of scECMh, bECMh and dECMh were sigmoidal, and gelation occurred within 40 min 194 
(Figure 2). The tlag and t1/2 was 1.40-1.53 fold lower for dECMh compared to sc ECMh and bECMh. However, 195 
the time required to reach 95% of the final turbidity is 0.75-0.84 fold lower for scECMh with respect to bECMh 196 
and dECMh. The gelation speed was 1.3 and 2.1 fold faster for scECMh compared to bECMh, dECMh 197 
respectively (Table 2).  198 
3.3 Influence of ECM origin on hydrogel mechanical properties 199 
Storage modulus (Gʹ) and loss modulus (Ǵ́́́́́́ʹ́́ ) of all the pre-gel solutions increased 5 min after pH neutralisation 200 
and temperature elevation and reached a maximum after 1 hr (Figure 3). G’ was consistently higher than G”, 201 
reflecting the formation of a solid hydrogel. Regardless of origin, hydrogels showed similar gelation profiles, 202 
although bECMh, dECMh and scECMh final moduli were significantly different (Table 3). bECMh had the 203 
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highest storage modulus (287.17 +/- 8.43 Pa); while scECMh and dECMh were significantly lower (19.35 +/- 204 
1.16 and 4.79 +/- 0.33 Pa, respectively). 205 
3.4 Influence of ECM origin on hydrogel microstructure  206 
The origin of hydrogel markedly influenced the hydrogel morphology.  While bECMh and dECMh exhibited 207 
a fibrillary structure with disorganised thin fibres (Figure 4A and B); scECMh showed a honeycomb structure 208 
with thick walls and large pores (Figure 4C). dECMh appeared to be composed of thicker fibres and smaller 209 
pores in comparison to bECMh. 210 
3.5 Influence of ECM origin on dental stem cell proliferation  211 
Regardless of the ECM origin, SCAP proliferated when incorporated in the ECM hydrogels. When cultured in 212 
3D, the number of SCAP increased between 0.36 and 1.47-fold 7 days post seeding and 2 to 4.78-fold 14 days 213 
post seeding compared to the initial seeding density (Figure 5A). No significant difference was observed 214 
between day 2 and 7 for any of the hydrogels, whilst SCAP proliferation significantly increased between day 215 
7 and day 14 for all of the hydrogels. The SCAP proliferation was 1.8 to 2.5-fold higher in scECMh compared 216 
to the dECMh and bECMh on day 14, respectively.  217 
When grown on the hydrogels (2D culture), the SCAP proliferation on various ECM hydrogels increased 218 
between 0.48 to 1-fold 7 days of post seeding and between 12.6 to 60-folds 14 days post seeding (Figure 5B). 219 
SCAP proliferation on tissue culture treated plastic (TCP) was much higher than either on 2D or in 3D 220 
hydrogels with a fold increases of 16.28 and 205.7 at day 7 and 14, respectively. No significant difference was 221 
observed between Day 2 and 7. 222 
3.6 Influence of SCAP incorporation into different ECM on cell viability  223 
SCAP viability 2 days after incorporation in all ECM hydrogels was above 65 % (Figure 6B). Viability was 224 
significantly higher in bECMh than in dECMh and scECMh (85 %, 65 % and 68 %, respectively). In general, 225 
SCAP morphology was elongated in all three ECM hydrogels, however some rounded cells were also observed 226 
in bECMh (Figure 6A).  227 
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3.7 Influence of ECM origin on SCAP gene expression 228 
The expression of genes related to the neural lineage (SNAIL, βIIITubulin, GDNF, VEGFA, PDGFRa, and 229 
GAPDH as a housekeeping gene) were analysed to determine whether ECM origin would elicit or support 230 
SCAP orientation. When SCAP were cultured routinely (Figure 7), GDNF and PDGFRa were slightly 231 
expressed but no expression of SNAIL, βIIITubulin or VEGFA was detected. When SCAP were incorporated 232 
in bECM, no expression of the gene of interest was detected at Day 2 and Day 7. SNAIL, βIIITubulin, GDNF, 233 
VEGFA and PDGFRa were expressed after 14 days of incubation in the hydrogel. SCAP incorporated in dECM 234 
showed no expression of the genes of interest. Only when SCAP were grown in scECM a marked expression 235 
of all the tested genes was detected after 7 days. 236 
4 Discussion 237 
The present study illustrates the influence of biological scaffolds derived from homologous and non-238 
homologous tissue on the gene expression profile of dental stem cells from apical papilla (SCAP). Previously 239 
published methods were employed to prepare ECM scaffolds derived from spinal cord (scECM) 20 and bone 240 
(bECM) 19. A new decellularisation method was developed for the preparation of dentine ECM scaffolds 241 
(dECM) based on the material characteristics and its similarity towards the bone tissue. 242 
The acellular nature of bECM, dECM, and scECM was determined by quantifying residual dsDNA content. 243 
The amount of dsDNA per mg of dry ECM present in bECM, dECM and scECM was considerably lower than 244 
the <50 ng threshold previously determined as an effective criteria for decellularisation 28. The presence of 245 
DNA and other cellular material, either xenogeneic or allogeneic in nature, within in the ECM scaffold due to 246 
inefficient decellularisation could potentially elicit host immunological response. However, it is unlikely that 247 
complete removal of cells will be obtained even with harsh decellularisation procedures 29. 248 
The percentage of collagen and glycosaminoglycan in the ECM scaffolds derived from bone, spinal cord and 249 
dentine varied depending upon the function and nature of tissue source. In addition to the intrinsic ECM 250 
composition influencing sGAG content, the higher sGAG content in scECMh could be due to the 251 
decellularisation process. It has been demonstrated previously that small intestinal mucosa-based ECM matrix 252 
 12 
sterilised with peracetic acid induced a greater loss of cellular components such as lipids, nucleic acids, and 253 
other undesirable elements ensuing more sGAG and FGF-2 compared to ECM non-treated with peracetic acid. 254 
We postulate that the higher sGAG content in scECM with respect to bECM and dECM might be due to the 255 
peracetic acid treatment during decellularization30.  Also, we hypothesize that the differences observed between 256 
ECM of different origins might be due to i) either different amounts of sGAG in the tissue before treatment or 257 
ii) to the different treatments used to obtain each ECM30,31. 258 
The gelation kinetics based on turbidimetry demonstrated that scECM, bECM and dECM hydrogels (Figure 259 
2) exhibited sigmoidal gelation kinetics. Although the speed to complete gelation as well as t95  were  greater 260 
for scECMh and bECMh, the lag time as well as t1/2 of dECMh was considerably lower with respect to bECMh; 261 
this is likely to be the effect of glycosaminoglycan presence during the in vitro self-assembly of collagen 262 
fibres32. 263 
It is noteworthy that the individual ECMs demonstrate distinct morphologies when analysed via scanning 264 
electron microscopy. The basal lamina of the spinal cord is comprised predominantly of collagen IV though 265 
types I and III are also present 33 whereas bone and dentine are composed primarily of collagen type I, with 266 
traces of type III, V, IX, XII, XIV, XIX, and XXI 34. We hypothesise that scECMh contains Type IV collagen 267 
that tends to form a flexible triple helix that self-assembles to incorporate structural glycoproteins 35, resulting 268 
in the sheet-like structure observed in Figure 4C. However in bECMh and dECMh collagen XII, XIV, XIX, 269 
and XXI serve as molecular bridges between collagen I monomers to produce fibrils.  270 
Rheology was used to study the viscoelastic properties of ECM hydrogels. It is interesting to note that 271 
regardless of the tissue origin, hydrogels exhibited similar sigmoidal shaped gelation profiles. However, the 272 
storage modulus for dECMh is considerably lower than scECMh and bECMh. We postulate that this difference 273 
is due to the disparity of source of tissue as well as the decellularisation processes. The potential impact of 274 
hydrogel solid content has been evaluated but no difference was visible between hydrogels of different origins 275 
(Supplementary data 2). We hypothesize that the degree of cross-linking could be responsible for the difference 276 
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of moduli, especially when considering the different morphologies observed with SEM36,37. Although the final 277 
moduli of dECM and scECM are lower than 0.1kPa, the final modulus of bECMh was in the range of 0.1-278 
1.0kPa. Hydrogels with elastic moduli within this range have been reported to have a positive influence on the 279 
probability of neuronal marker expression and neuronal differentiation38. 280 
Several authors have emphasised the intrinsic ability of ECM derived scaffolds to aid viability, migration and 281 
proliferation of numerous cell types 9,39. Nevertheless, the present study is the first time ECM scaffolds from 282 
decellularised bone, dentine and spinal cord have been used as a 3D culture system for apical papilla stem cells.  283 
High cell viability (Figure 6) was observed in bECMh, scECMh and dECMh, confirming the suitability of 284 
these scaffolds as delivery vehicles for SCAP. Greater cell viability was observed in bECMh compared to 285 
dECMh and scECMh. The choice of detergents used for the decellularisation procedure could have a marked 286 
deleterious effect up on the ECM 40. We hypothesise that the lower cell viability observed in scECMh may be 287 
due to traces of residual detergent present after decellularisation.  This is the first time that dentine has been 288 
decellularised and further studies may be needed to optimise the duration as well as the concentration of HCl 289 
solution used in the enamel removal step.  We postulate that too harsh treatment applied during 290 
decellularisation procedure may have led to the lower cell viability observed in dECMh 291 
In both 2D and 3D culture environment, SCAP proliferated till day 7 irrespective of the culture conditions 292 
(Figure 5). However, in the 2D environment, there was a remarkable increase in the proliferation between day 293 
7 and day 14 for SCAP grown on TCP and dECMh. We postulate that after the initial phase of cell and ECM 294 
hydrogel interaction, the surface with higher elasticity (dECMh) facilitated quicker cell migration and 295 
proliferation compared to the more rigid surfaces of bECMh and scECMh. SCAP grown in 2D culture 296 
proliferated faster than SCAP grown in 3D. Cell movement on 2D environment is relatively unrestricted; 297 
whereas in a 3D environment, cells need to degrade their adjacent material enzymatically in order to migrate 298 
41. Furthermore, in 2D culture, the cells are exposed to a homogenous concentration of nutrients which 299 
influence their proliferation and differentiation in comparison to the gradient pattern observed in 3D 300 
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environment 42. We also postulate that the porous structure of scECMh (Figure 4C) facilitated greater 301 
proliferation rate in 3D environment compared to bECMh and dECMh.  302 
A slight expression of some neural lineage markers by non-differentiated SCAP, attributed to their neural crest 303 
origin, was reported previously 43. When SCAP were embedded into scECMh, there was a remarkable 304 
expression of key neural lineage markers on day 7 and day 14 (Figure 7). We hypothesise that the potential 305 
neurotrophic factors as well as proteoglycans embedded within scECMh have induced a neural-like phenotype. 306 
ECM scaffolds derived from CNS tissues have already been reported to induce neuronal cell differentiation of 307 
neuronal progenitor cells 9,20,23. Furthermore, decellularisation using peracetic acid might have resulted in a 308 
higher concentration of FGF-2 as well as sGAG 44, which in turn enhanced the gene expression of neuronal 309 
lineage markers in scECMh. On day 14, SCAP embedded in bECMh also showed an expression of neural 310 
lineage genes. We hypothesise that the by-products of ECM degradation including soluble biomolecules in 311 
conjunction with scaffold elasticity may influence SCAP differentiation towards neural phenotype.  312 
5 Conclusion 313 
Solubilised forms of decellularised ECM from spinal cord, dentine and bone tissues were prepared by a 314 
combination of enzymatic and chemical processes and induced to form hydrogels. These acellular ECM 315 
hydrogels had discrete structural, mechanical and biological characteristics. Human stem cells from apical 316 
papilla exhibited a strong positive response to scECMh by proliferating within and on the hydrogel and by 317 
expressing neural genes; substantiating the influence of neurotrophic factors present in decellularized spinal 318 
cord. SCAP exhibited a greater proliferation rate in 2D in dECMh, compared to bECMh and scECMh, however 319 
no neuronal differentiation occurred. Neuronal lineage markers were expressed by SCAP when cultured with 320 
bECMh and it is hypothesized that the hydrogel mechanical properties combined with active biomolecules 321 
provided the stimulus for this behaviour. The results of the present study show that decellularised ECM 322 
hydrogels facilitate SCAP viability and proliferation. However, ECM hydrogels from site-specific tissues 323 
demonstrated are more likely to facilitate optimal stem cell behaviour for constructive spinal cord regeneration. 324 
 15 
 325 
Acknowledgements  326 
The authors would like to thank Dr Christopher Medberry and Professor Stephen Badylak for assistance with 327 
preparation of the spinal cord ECM. The authors also would like to thank MICA - Université Catholique de 328 
Louvain platform for Scanning Electron Microscope facility. Aiswarya Viswanath is supported by NanoFar 329 
"European Doctorate in Nanomedicine" EMJD programme funded by EACEA. This work is supported by 330 
grants from the Université Catholique de Louvain (F.S.R), Fonds National de la Recherché Scientifique 331 
(F.R.S.-FNRS). A. des Rieux is a F.R.S.-FNRS Research Associate and J. Vanacker is a F.R.S.-FNRS 332 
Postdoctoral Researcher. J. Leprince is supported by la Fondation Saint Luc. 333 
References 334 
1. McCreedy DA, Sakiyama-Elbert SE. Combination therapies in the CNS: engineering the environment. Neurosci 335 
Lett 2012;519(2):115-21. 336 
2. Tator CH. Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. 337 
Neurosurgery 2006;59(5):957-82; discussion 982-7. 338 
3. Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest 2012;122(11):3824-34. 339 
4. De Berdt P, Vanacker J, Ucakar B, Elens L, Diogenes A, Leprince JG, Deumens R, des Rieux A. Dental Apical Papilla 340 
as Therapy for Spinal Cord Injury. J Dent Res 2015;94(11):1575-81. 341 
5. Huang GT-J, Gronthos S, Shi S. Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other 342 
Sources: Their Biology and Role in Regenerative Medicine. Journal of Dental Research 2009;88(9):792-806. 343 
6. Sakai K, Yamamoto A, Matsubara K, Nakamura S, Naruse M, Yamagata M, Sakamoto K, Tauchi R, Wakao N, 344 
Imagama S and others. Human dental pulp-derived stem cells promote locomotor recovery after complete 345 
transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest 2012;122(1):80-90. 346 
7. Martens W, Bronckaers A, Politis C, Jacobs R, Lambrichts I. Dental stem cells and their promising role in neural 347 
regeneration: an update. Clin Oral Investig 2013;17(9):1969-83. 348 
 16 
8. Sonoyama W, Liu Y, Yamaza T, Tuan RS, Wang S, Shi S, Huang GT. Characterization of the apical papilla and its 349 
residing stem cells from human immature permanent teeth: a pilot study. J Endod 2008;34(2):166-71. 350 
9. Crapo PM, Tottey S, Slivka PF, Badylak SF. Effects of biologic scaffolds on human stem cells and implications for 351 
CNS tissue engineering. Tissue Eng Part A 2014;20(1-2):313-23. 352 
10. Bible E, Dell'Acqua F, Solanky B, Balducci A, Crapo PM, Badylak SF, Ahrens ET, Modo M. Non-invasive imaging 353 
of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- 354 
and diffusion-MRI. Biomaterials 2012;33(10):2858-71. 355 
11. Sicari BM, Dziki JL, Siu BF, Medberry CJ, Dearth CL, Badylak SF. The promotion of a constructive macrophage 356 
phenotype by solubilized extracellular matrix. Biomaterials 2014;35(30):8605-8612. 357 
12. Wolf MT, Carruthers CA, Dearth CL, Crapo PM, Huber A, Burnsed OA, Londono R, Johnson SA, Daly KA, Stahl EC 358 
and others. Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body 359 
response. J Biomed Mater Res A 2014;102(1):234-46. 360 
13. Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faulk DM, Wang J, Mayle KM, Bartels 361 
K, Salvatore M and others. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular 362 
matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am 363 
Coll Cardiol 2012;59(8):751-63. 364 
14. Wang RM, Christman KL. Decellularized myocardial matrix hydrogels: In basic research and preclinical studies. 365 
Adv Drug Deliv Rev 2015. 366 
15. Ballios BG, Cooke MJ, Donaldson L, Coles BL, Morshead CM, van der Kooy D, Shoichet MS. A Hyaluronan-Based 367 
Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following Transplantation. Stem 368 
Cell Reports 2015;4(6):1031-45. 369 
16. DeQuach JA, Yuan SH, Goldstein LS, Christman KL. Decellularized porcine brain matrix for cell culture and tissue 370 
engineering scaffolds. Tissue Eng Part A 2011;17(21-22):2583-92. 371 
17. Sellaro TL, Ranade A, Faulk DM, McCabe GP, Dorko K, Badylak SF, Strom SC. Maintenance of Human Hepatocyte 372 
Function In Vitro by Liver-Derived Extracellular Matrix Gels. Tissue Engineering Part A 2010;16(3):1075-1082. 373 
 17 
18. Sellaro TL, Ravindra AK, Stolz DB, Badylak SF. Maintenance of hepatic sinusoidal endothelial cell phenotype in 374 
vitro using organ-specific extracellular matrix scaffolds. Tissue Eng 2007;13(9):2301-10. 375 
19. Sawkins MJ, Bowen W, Dhadda P, Markides H, Sidney LE, Taylor AJ, Rose FR, Badylak SF, Shakesheff KM, White 376 
LJ. Hydrogels derived from demineralized and decellularized bone extracellular matrix. Acta Biomater 377 
2013;9(8):7865-73. 378 
20. Medberry CJ, Crapo PM, Siu BF, Carruthers CA, Wolf MT, Nagarkar SP, Agrawal V, Jones KE, Kelly J, Johnson SA 379 
and others. Hydrogels derived from central nervous system extracellular matrix. Biomaterials 2013;34(4):1033-380 
40. 381 
21. Bazos P, Magne P. Bio-emulation: biomimetically emulating nature utilizing a histo-anatomic approach; 382 
structural analysis. Eur J Esthet Dent 2011;6(1):8-19. 383 
22. Hong Y, Huber A, Takanari K, Amoroso NJ, Hashizume R, Badylak SF, Wagner WR. Mechanical properties and in 384 
vivo behavior of a biodegradable synthetic polymer microfiber-extracellular matrix hydrogel biohybrid scaffold. 385 
Biomaterials 2011;32(13):3387-94. 386 
23. Crapo PM, Medberry CJ, Reing JE, Tottey S, van der Merwe Y, Jones KE, Badylak SF. Biologic scaffolds composed 387 
of central nervous system extracellular matrix. Biomaterials 2012;33(13):3539-3547. 388 
24. Woessner JF, Jr. The determination of hydroxyproline in tissue and protein samples containing small 389 
proportions of this imino acid. Arch Biochem Biophys 1961;93:440-7. 390 
25. Farndale RW, Sayers CA, Barrett AJ. A Direct Spectrophotometric Micro-Assay for Sulfated Glycosaminoglycans 391 
in Cartilage Cultures. Connective Tissue Research 1982;9(4):247-248. 392 
26. Wolf MT, Daly KA, Brennan-Pierce EP, Johnson SA, Carruthers CA, D'Amore A, Nagarkar SP, Velankar SS, Badylak 393 
SF. A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials 2012;33(29):7028-38. 394 
27. Ruparel NB, de Almeida JF, Henry MA, Diogenes A. Characterization of a stem cell of apical papilla cell line: 395 
effect of passage on cellular phenotype. J Endod 2013;39(3):357-63. 396 
28. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. 397 
Biomaterials 2011;32(12):3233-3243. 398 
 18 
29. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Seminars in Immunology 399 
2008;20(2):109-116. 400 
30. Engfeldt B, Hjerpe A. Glycosaminoglycans of dentine and predentine. Calcif Tissue Res 1972;10(2):152-9. 401 
31. Liu Z, Masuko S, Solakyildirim K, Pu D, Linhardt RJ, Zhang F. Glycosaminoglycans of the porcine central nervous 402 
system. Biochemistry 2010;49(45):9839-47. 403 
32. Stuart K, Panitch A. Influence of chondroitin sulfate on collagen gel structure and mechanical properties at 404 
physiologically relevant levels. Biopolymers 2008;89(10):841-51. 405 
33. Weidner N, Grill RJ, Tuszynski MH. Elimination of basal lamina and the collagen "scar" after spinal cord injury 406 
fails to augment corticospinal tract regeneration. Exp Neurol 1999;160(1):40-50. 407 
34. Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol 2008;3 Suppl 3:S131-9. 408 
35. Burnside ER, Bradbury EJ. Manipulating the extracellular matrix and its role in brain and spinal cord plasticity 409 
and repair. Neuropathol Appl Neurobiol 2014;40(1):26-59. 410 
36. Black LD, Allen PG, Morris SM, Stone PJ, Suki B. Mechanical and failure properties of extracellular matrix sheets 411 
as a function of structural protein composition. Biophys J 2008;94(5):1916-29. 412 
37. Marinkovic M, Block TJ, Rakian R, Li Q, Wang E, Reilly MA, Dean DD, Chen XD. One size does not fit all: 413 
developing a cell-specific niche for in vitro study of cell behavior. Matrix Biol 2016;52-54:426-41. 414 
38. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 415 
2006;126(4):677-89. 416 
39. Tukmachev D, Forostyak S, Koci Z, Zaviskova K, Vackova I, Vyborny K, Sandvig I, Sandvig A, Medberry CJ, Badylak 417 
SF and others. Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair. Tissue Eng 418 
Part A 2016;22(3-4):306-17. 419 
40. Faulk DM, Carruthers CA, Warner HJ, Kramer CR, Reing JE, Zhang L, D'Amore A, Badylak SF. The effect of 420 
detergents on the basement membrane complex of a biologic scaffold material. Acta Biomater 2014;10(1):183-421 
93. 422 
41. Walters NJ, Gentleman E. Evolving insights in cell-matrix interactions: elucidating how non-soluble properties 423 
of the extracellular niche direct stem cell fate. Acta Biomater 2015;11:3-16. 424 
 19 
42. Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 425 
2009;103(4):655-63. 426 
43. Germain L, De Berdt P, Vanacker J, Leprince J, Diogenes A, Jacobs D, Vandermeulen G, Bouzin C, Préat V, 427 
Dupont-Gillain C and others. Fibrin hydrogels to deliver dental stem cells of the apical papilla for regenerative 428 
medicine. Regenerative Medicine 2015;10(2):153-167. 429 
44. Hodde J, Janis A, Ernst D, Zopf D, Sherman D, Johnson C. Effects of sterilization on an extracellular matrix 430 
scaffold: part I. Composition and matrix architecture. J Mater Sci Mater Med 2007;18(4):537-43. 431 
 432 
  433 
 20 
Tables and Figures 434 
 435 
Table 1: Human genes and primers used for RT-PCR analysis 436 
 437 
Symbol Gene name Primer Sequence (5’->3’) Amplicon 
length (bp) 
GAPDH GAPDH = Glyceraldehyde 
3-phosphate dehydrogenase 
 
F :  GATCAACTCACCGCCAACA 
R : CCAGCGACTCAATCTTCCTC  
452 
SNAIL Zinc finger protein SNAI1 F : CTAGGCCCTGGCTGCTACAA 
R :CATCTGAGTGGGTCTGGAGGT 
129 
BIII 
Tubulin 
 F : GGGCCTTTGGACATCTCTTC 
R : GGATACTCCTCACGCACCTT 
244 
PDGFRa Platelet-Derived Growth 
Factor Receptor, Alpha 
Polypeptide 
F : AGCTTGAAGGCAGGCACA 
R :GCGACAAGGTATAATGGCAG
A 
122 
VEGFA Vascular endothelial growth 
factor A 
F : CATCTTCAAGCCATCCTGTG  
R : CAACGCGAGTCTGTGTTTT  
303,357, 
375,426 
GDNF Glial cell derived 
neurotrophic factor 
F : CAGACATCTGATCCCCTTCC 
R : GCTGGGGTTTGTCACTGTTT 
172 
 438 
 439 
 440 
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 441 
Table 2: Gelation kinetics for scECM, bECM and dECM hydrogels 442 
 443 
 
Turbidity (Mean± SD) 
 
 
scECM (Mean± SD) 
 
bECM (Mean± SD) 
 
dECM (Mean± SD) 
Lag phase      (t lag: min) 11.998 ± 1.90 11.25 ± 1.4 7.8 ± 1.55 
50% gelation (t ½: min) 20.582 ± 2.42 21.06 ± 3.2 14.60 ± 1.24 
95% gelation (t 95: min) 30.248 ± 2.91 36.00± 0.00 39.85 ± 3.34 
Speed             (S, min-1) 0.0738 ± 0.009 0.057 ± 0.003 0.035 ± 0.004 
n=8, p<0.05 444 
  445 
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Table 3: Influence of ECM origin on hydrogel final moduli 446 
 Material  Storage modulus (G’, Pa)      Loss modulus (G’’, Pa) 447 
bECM (8mg/ml)             287.17 ± 8.43 A              42.61 ± 3.72 A  448 
dECM (8mg/ml)             4.79 ± 0.33 B   0.56 ± 0.128 B 449 
scECM (8mg/ml)             19.35 ± 1.16 C               2.40 ± 0.385 C 450 
ECM not related by the same letter are significantly different (G’ and G’’ separately) (p<0.05; n=3). 451 
  452 
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 453 
454 
Figure 1: Influence of ECM origin on cellular, collagen and sGAG content. 455 
(A) Efficiency of decellularisation was assessed by quantifying the amount of dsDNA/mg dry weight. B) 456 
Collagen content and (C) sGAG content of ECM scaffolds were evaluated by quantifying hydroxyproline and 457 
using the 1, 9 –Dimethyl methylene blue assay, respectively. Data is presented as Mean ± standard 458 
deviation (n=3). Conditions not linked by the same letter are significantly different (p<0.05). 459 
  460 
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 461 
Figure 2: Turbidimetric gelation kinetics of scECM, bECM, and dECM scaffolds were compared at 8mg/ml 462 
concentrations. The neutralised pre-gel solution was added to a 96 well plate and gelation was induced at 463 
370C. The absorbance was measured at 405nm and recorded at 3min intervals. The data was normalised 464 
between 0 (initial absorbance) and 1 (maximum absorbance). Data represents mean ± SD (n=8). Inset: 465 
diagrammatic representation of the parameters determined from normalised gelation kinetics.  466 
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Figure 3: Influence of ECM origin on hydrogel mechanical properties. 468 
Rheological properties of hydrogels were investigated by small amplitude oscillatory shear rheology. 469 
The storage (G′) and loss moduli (G′′) were measured using a Kinexus Pro rotational rheometer and 470 
rSpace software (n=3). 471 
  472 
 27 
 473 
 474 
Figure 4: Influence of ECM origin on the hydrogel microstructure. 475 
ECM hydrogels were formed and processed for SEM analysis, scale bar = 1 μm with (A) bECM, (B) dECM 476 
and (C) scECM hydrogels. Magnification: 12,000x.  477 
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 478 
Figure 5: Influence of ECM origin on SCAP proliferation. 479 
A- 500,000 SCAP/ml were incorporated in different ECM hydrogels and incubated at 37°C. Presto blue 480 
test was performed at different time points (2, 7 and 14 days). Fluorescence intensities were measured 481 
at 590 nm (n=6, N=3). B- Pre-gel solutions were allowed to gel at 37°C. Then 2000 SCAP were seeded 482 
on the ECM. After 2, 7 and 14 days, cell proliferation was analysed using a Presto Blue kit (n=6, N=3). 483 
As a positive control, the same amount of cells was seeded on tissue culture plastic. Conditions not 484 
related by the same letter are significantly different (p < 0.05). 485 
  486 
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 487 
Figure 6: Influence of ECM origin on SCAP viability. 488 
500,000 SCAP/ml were incorporated in different ECM hydrogels and incubated for 2 days. A 489 
Live/Dead assay was performed. Living and dead cells were observed by confocal microscopy (488 490 
and 568 nm, respectively) (n=3, N=3). (A) Live cells were stained with Calcein (green) and dead cells 491 
were stained with ethidium homodimer-I (red). (B) The images were processed to quantify the number 492 
of live cells and dead cells using ImageJ (n = 3–5 acquisitions/sample). Conditions not related by the 493 
same letter are significantly different (p< 0.05). 494 
  495 
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 496 
Figure 7: Influence of ECM origin on SCAP gene expression. 497 
500,000 SCAP/ml were incorporated in different ECM hydrogels and incubated for 2, 7 and 14 days 498 
(D2, D7 and D14). mRNA were extracted and gene expression was analysed by RT-PCR (n=3, N=3). 499 
Blanks (Blk) were obtained by replacing mRNA by RNAse free water. Gene expression of SCAP 500 
grown in 2D without ECM hydrogel (SCAP) was also analysed. 501 
